Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Amit Sanyal, MD: A Clinician’s Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Oct
04
Today In Oncology
Impact of Proton and Photon Therapy on HRQOL in Breast Cancer
Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy
Study Shows That After Early Breast Cancer Diagnosis, Risk of a Second Cancer is Low
Advanced or Metastatic Breast Cancer: FDA Approves Imlunestrant for ER-Positive, HER2-Negative, ESR1-Mutated Disease
Use of Obecabtagene Autoleucel CAR T-Cell Therapy for B-Cell Acute Lymphocytic Leukemia
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo